CoChat

p400 Is Required for E1A to Promote Apoptosis

Open access
Samuelson, Andrew V., Narita, Masako, Chan, Ho-Man, Jin, Jianping, de Stanchina, Elisa, McCurrach, Mila E., Narita, Masashi, Fuchs, Miriam, Livingston, David M., Lowe, Scott W. · 2005 · Journal of Biological Chemistry
Cited by 59

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The adenovirus E1A oncoprotein promotes proliferation and transformation by binding cellular proteins, including members of the retinoblastoma protein family, the p300/CREB-binding protein transcriptional coactivators, and the p400-TRRAP chromatin-remodeling complex. E1A also promotes apoptosis, in part, by engaging the ARF-p53 tumor suppressor pathway. We show that E1A induces ARF and p53 and promotes apoptosis in normal fibroblasts by physically associating with the retinoblastoma protein and a p400-TRRAP complex and that its interaction with p300 is largely dispensable for these effects. We further show that E1A increases p400 expression and, conversely, that suppression of p400 using stable RNA interference reduces the levels of ARF, p53, and apoptosis in E1A-expressing cells. Therefore, whereas E1A inactivates the retinoblastoma protein, it requires p400 to efficiently promote cell death. These results identify p400 as a regulator of the ARF-p53 pathway and a component of the cellular machinery that couples proliferation to cell death. The adenovirus E1A oncoprotein promotes proliferation and transformation by binding cellular proteins, including members of the retinoblastoma protein family, the p300/CREB-binding protein transcriptional coactivators, and the p400-TRRAP chromatin-remodeling complex. E1A also promotes apoptosis, in part, by engaging the ARF-p53 tumor suppressor pathway. We show that E1A induces ARF and p53 and promotes apoptosis in normal fibroblasts by physically associating with the retinoblastoma protein and a p400-TRRAP complex and that its interaction with p300 is largely dispensable for these effects. We further show that E1A increases p400 expression and, conversely, that suppression of p400 using stable RNA interference reduces the levels of ARF, p53, and apoptosis in E1A-expressing cells. Therefore, whereas E1A inactivates the retinoblastoma protein, it requires p400 to efficiently promote cell death. These results identify p400 as a regulator of the ARF-p53 pathway and a component of the cellular machinery that couples proliferation to cell death. Normal cells possess innate tumor suppressor mechanisms that couple proliferation to apoptosis, thereby limiting the transforming potential of oncogenic mutations (reviewed in Ref. 1Lowe S.W. Cepero E. Evan G. Nature. 2004; 432: 307-315Crossref PubMed Scopus (1056) Google Scholar). For example, overexpression of the c-myc oncogene or loss of the retinoblastoma protein (Rb) 1The abbreviations used are: Rb, retinoblastoma protein; CBP, CREB-binding protein; cAMP-response element-binding protein; MEF, mouse embryo fibroblast; shRNA, short hairpin RNA. tumor suppressor deregulates cell cycle control but also can promote apoptosis. Consequently, cells with these lesions proliferate inappropriately but also become hypersensitive to apoptosis in response to survival factor depletion and DNA-damaging agents. Subsequent mutations that disable apoptosis allow proliferation to continue unabated, leading to oncogenic transformation or tumor progression. The ARF-p53 pathway is an important circuit in the signaling network that couples proliferation to cell death (2Sherr C.J. Nat. Rev. Mol. Cell. Biol. 2001; 2: 731-737Crossref PubMed Scopus (826) Google Scholar). ARF is the alternative reading frame product of the INK4a/ARF tumor suppressor locus, which also encodes the cyclin-dependent kinase inhibitor p16INK4a. Several oncogenes, including c-Myc and E1A, induce ARF message and protein, which in turn activates p53 by interfering with its negative regulator Mdm2 (2Sherr C.J. Nat. Rev. Mol. Cell. Biol. 2001; 2: 731-737Crossref PubMed Scopus (826) Google Scholar). p53, in turn, increases the transcription of genes that ultimately target different components of the apoptotic machinery (3Fridman J.S. Lowe S.W. Oncogene. 2003; 22: 9030-9040Crossref PubMed Scopus (1153) Google Scholar). Although oncogenes can also promote apoptosis through ARF- and p53-independent mechanisms, apoptosis induced by Myc or E1A is severely compromised in cells lacking ARF or p53 (4Zindy F. Eischen C.M. Randle D.H. Kamijo T. Cleveland J.L. Sherr C.J. Roussel M.F. Genes Dev. 1998; 12: 2424-2433Crossref PubMed Scopus (1060) Google Scholar, 5de Stanchina E. McCurrach M.E. Zindy F. Shieh S.Y. Ferbeyre G. Samuelson A.V. Prives C. Roussel M.F. Sherr C.J. Lowe S.W. Genes Dev. 1998; 12: 2434-2442Crossref PubMed Scopus (546) Google Scholar), and loss of ARF or p53 can cooperate with proapoptotic oncogenes to promote transformation in vitro and tumorigenesis in mice (reviewed in Refs. 1Lowe S.W. Cepero E. Evan G. Nature. 2004; 432: 307-315Crossref PubMed Scopus (1056) Google Scholar and 6Lowe S.W. Sherr C.J. Curr. Opin. Genet. Dev. 2003; 13: 77-83Crossref PubMed Scopus (616) Google Scholar). How ARF senses hyperproliferative signals is poorly understood, but it can involve transcriptional control of the ARF promoter by E2F proteins as well as control of higher order chromatin structure

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m414564200

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 59

Metadata

Authors
Samuelson, A. V., Narita, M., Chan, H.-M., Jin, J., de Stanchina, E., McCurrach, M. E., Narita, M., Fuchs, M., Livingston, D. M., & Lowe, S. W.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-06
Volume
280
Issue
23
Pages
21915-21923
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2013816574
Cited by
59
References
10
FWCI
2.40
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.